Categories: Pharma & Healthcare
Format :
Market Overview
The global Micro-Invasive Glaucoma Surgery Devices Market anticipated to grow at a CAGR of 34.45% to reach US$ 5234.56 Million by the end of 2030.
Market Report Service Insights can provide in-depth research reports highlighting Market and competitive information in key Market segments. The report also considers the impact of COVID-19 on the global Micro-Invasive Glaucoma Surgery Devices Market. This report considers the historical period 2018-2022, the base year 2022, and the forecast period 2023-2030. This report provides a quantitative analysis of the Market supported by Market drivers, challenges, and trends to accurately describe the Market scenario and competition.
Key Development
In January 2022, Glaukos announced GLK=301's first patient enrolment in the Phase II clinical trial for dry eye disease. After the successful approval from the regulatory body, this drug will help the company grow its business segment.
In January 2022, Alcon acquired Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device. This surgical device is designed to lower eye pressure for open-angle glaucoma patients. This acquisition will enhance the company’s portfolio in eye surgery segment.
Report Scope
Report Data | Micro-Invasive Glaucoma Surgery Devices Market |
Micro-Invasive Glaucoma Surgery Devices Market Forecast | 5234.56 Million (2023-2030) |
Micro-Invasive Glaucoma Surgery Devices Market CAGR 2023 - 2030 | 34.45% |
Micro-Invasive Glaucoma Surgery Devices Market Analysis Period | 2023 - 2030 |
Micro-Invasive Glaucoma Surgery Devices Market Base Year | 2022 |
Micro-Invasive Glaucoma Surgery Devices Market Forecast Data | 2023 - 2030 |
Segments Covered | By Type, By Application, And by Regions |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled | Glaukos, Alcon, iSTAR Medical, Ivantis, Allergan, Santen Pharmaceuticals, InnFocus |
Key Segments | Key Segment by Type
Key Segment by Application
|
Report Coverage | Market Drivers, Market Trends, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
FAQ
The global Micro-Invasive Glaucoma Surgery Devices Market anticipated to grow at a CAGR of 34.45% to reach US$ 5234.56 Million by the end of 2030.
North America is expected to hold the largest share of the global Micro-Invasive Glaucoma Surgery Devices Market.
The key Micro-Invasive Glaucoma Surgery Devices Market players profiled in the report include Glaukos, Alcon, iSTAR Medical, Ivantis, Allergan, Santen Pharmaceuticals, InnFocus and others.
Global Micro-Invasive Glaucoma Surgery Devices Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
Corporate strategies have a separate section:
Companies are focusing on cross-border development, product differentiation and other methods to maintain Market share. Established companies in particular need to understand the overall Market composition and the capabilities of regional players in order to implement these approaches.
The study provides company profiles with detailed reports on key metrics. These developments give readers the knowledge they need to make smart decisions while also helping them focus on attracting customers and growing their businesses.
Due to the unexpected COVID-19 epidemic, there is a temporary shift in the demand of the global Micro-Invasive Glaucoma Surgery Devices Market.
As a result, Market sizes that accurately represent the impact of COVID-19 can be assessed and predicted using real-time trends.
Key reasons to buy this report:
The present day in addition to the destiny market outlook of the enterprise regarding latest tendencies which contain boom possibilities and drivers in addition to demanding situations and restraints of each rising in addition to evolved regions.
Base Year:2022
Historical Data:2017-2022
No of Pages:162
Single User
Multi User
Corporate User
Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 3450
Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.
US $ 5250
The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.
US $ 7000
Email: [email protected]